ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Recent studies have suggested that adiponectin and its receptors in the liver may mediate ameliorative effects in obesity-induced MASLD, thus playing an important role in the crosstalk between the adipose tissue and liver.97